Anecortave Acetate Vehicle
Sponsors
Alcon Research
Conditions
AMDAge-Related MaculopathiesAge-Related MaculopathyDry AMDEye DiseasesMacular DegenerationMaculopathies, Age-RelatedMaculopathy, Age-Related
Phase 2
Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation
CompletedNCT00315640
Start: 2005-12-31End: 2009-07-31Updated: 2012-11-28
Anecortave Acetate in Patients With Open-angle Glaucoma
CompletedNCT00320203
Start: 2006-03-31End: 2008-01-31Updated: 2012-11-28
A Phase II Study of Anecortave Acetate for the Treatment of Exudative Age-Related Macular Degeneration
CompletedNCT00346957
Start: 1999-04-30End: 2003-04-30Updated: 2012-03-06
Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma
CompletedNCT00451152
Start: 2007-03-31End: 2009-07-31Updated: 2012-11-28
Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension
CompletedNCT00691717
Start: 2008-06-30End: 2009-09-30Updated: 2012-11-28
A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension
TerminatedNCT00788541
Start: 2008-12-31End: 2009-09-30Updated: 2012-11-30
Phase 3
Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD)
CompletedNCT00051129
Start: 2007-01-31End: 2008-05-31Updated: 2012-11-28
Anecortave Acetate in Patients With Exudative Age-related Macular Degeneration (AMD)
CompletedNCT00299507
Start: 2005-03-31End: 2008-04-30Updated: 2012-11-28
Anecortave Acetate Risk-Reduction Trial (AART)
TerminatedNCT00307398
Start: 2004-03-31End: 2009-01-31Updated: 2012-11-28
Anecortave Acetate Risk Reduction Trial (AART)
TerminatedNCT00332657
Start: 2006-09-30End: 2008-12-31Updated: 2012-11-28
Anecortave Acetate Risk-Reduction Trial (AART)
TerminatedNCT00333216
Start: 2005-05-31End: 2008-12-31Updated: 2012-11-28